Hypercholesterolemia in Asperger syndrome: Independence from lifestyle, obsessive-compulsive behavior, and social anxiety

Psychiatry Research

Volumn 149, Issue 1-3, 2007, Pages 321-324

  Dziobek, Isabel ^a,b   Gold, Stefan M ^a   Wolf, Oliver T ^b   Convit, Antonio ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIELEFELD UNIVERSITY   (Germany)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Autism; Etiology; Lipid profile

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ASPERGER SYNDROME; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SOCIAL PHOBIA; SYMPTOMATOLOGY;

ADULT; ASPERGER SYNDROME; BODY MASS INDEX; CHOLESTEROL; COGNITION DISORDERS; DEMOGRAPHY; FEMALE; HUMANS; HYDROCORTISONE; HYPERCHOLESTEROLEMIA; LIFE STYLE; MALE; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; PHOBIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 33846349917     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.02.003     Document Type: Article

References (21)

1. Block G., Gillespie C., Rosenbaum E.H., and Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. American Journal of Preventive Medicine 18 (2000) 284-288
2. Brambilla P., Hardan A., di Nemi S.U., Perez J., Soares J.C., and Barale F. Brain anatomy and development in autism: review of structural MRI studies. Brain Research Bulletin 61 (2003) 557-569
3. Chugani D.C. Serotonin in autism and pediatric epilepsies. Mental Retardation and Developmental Disabilities Research Reviews 10 (2004) 112-116
4. Clark-Taylor T., and Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial [beta]-oxidation by long chain acyl-CoA dehydrogenase. Medical Hypotheses 62 (2004) 970-975
5. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., Bento C., Marques C., Ataide A., Miguel T., Borges L., and Vicente A.M. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry 9 (2004) 264-271
6. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., and Oja P. International Physical Activity Questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 35 (2003) 1381-1395
7. Durstine L.J., Grandjean P.W., Cox C.A., and Thompson P.D. Lipids, lipoproteins, and exercise. Journal of Cardiopulmonary Rehabilitation 22 (2002) 385-398
8. Foa E.B., Huppert J.D., Leiberg S., Langner R., Kichic R., Hajcak G., and Salkovskis P.M. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychological Assessment 14 (2002) 485-496
9. Herbert M.R., Ziegler D.A., Makris N., Filipek P.A., Kemper T.L., Normandin J.J., Sanders H.A., Kennedy D.N., and Caviness V.S. Localization of white matter volume increase in autism and developmental language disorder. Annals of Neurology 55 (2004) 530-540
10. Huang T.L., Wu S.C., Chiang Y.S., and Chen J.F. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Research 118 (2003) 147-153
11. Landen M., Baghaei F., Rosmond R., Holm G., Bjorntorp P., and Eriksson E. Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety. Psychoneuroendocrinology 29 (2004) 1037-1046
12. Monteleone P., Santonastaso P., Pannuto M., Favaro A., Caregaro L., Castaldo E., Zanetti T., and Maj M. Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Research 134 (2005) 267-273
13. Mulder E.J., Anderson G.M., Kema I.P., de Bildt A., van Lang N.D., den Boer J.A., and Minderaa R.B. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry 43 4 (2004) 491-499
14. Oakman J., Van Ameringen M., Mancini C., and Farvolden P. A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale. Journal of Clinical Psychology 59 (2003) 149-161
15. Peter H., Hand I., Hohagen F., Koenig A., Mindermann O., Oeder F., and Wittich M. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Canadian Journal of Psychiatry 47 (2002) 557-561
16. Prado W.M., and Taub D.V. Accurate predication of individual intellectual functioning by the Shipley-Hartford. Journal of Clinical Psychology 22 (1966) 294-296
17. Salvati S., Attorri L., Avellino C., Di Biase A., and Sanchez M. Diet, lipids and brain development. Developmental Neuroscience 22 (2000) 481-487
18. Sevincok L., Buyukozturk A., and Dereboy F. Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder. Canadian Journal of Psychiatry 46 (2001) 68-71
19. Steegmans P.H., Fekkes D., Hoes A.W., Bak A.A., van der Does E., and Grobbee D.E. Low serum cholesterol concentration and serotonin metabolism in men. British Medical Journal 312 (1996) 221
20. Tierney E., Nwokoro N.A., Porter F.D., Freund L.S., Ghuman J.K., and Kelley R.I. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. American Journal of Medical Genetics 98 (2001) 191-200
21. Zachary R.A., Paulson M.J., and Gorsuch R.L. Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms. Journal of Clinical Psychology 41 (1985) 820-831